Investor Presentaiton

Maintain Market Share of Existing APIs - 2017 Major Products account for 50% of total sales API Product # of US DMF/EDMF & other filings Indication MKT share* Irinotecan HCI Antineoplastic 37% 64 Exemestane Antineoplastic 25% 46 Paclitaxel Antineoplastic 21% 60 60 Gemcitabine Antineoplastic 17% 76 Docetaxel Antineoplastic 15% 72 Anhydrous 32 32 *Source: IMS data from Newport ScinoPharm

View entire presentation